Visit our booth at "OTS"

📅October 19-22, 2025.
📍Budapest (HU) - Booth #29

As a leading therapeutic oligonucleotide manufacturer (CDMO), Eurogentec offers comprehensive end-to-end solutions for the development and manufacturing of high-quality oligonucleotides for innovative therapies. Our state-of-the-art facilities and team of experts ensure efficient and reliable production, from preclinical to clinical phases.

Learn more about our GMP Oligo manufacturing & CMC Services :

Therapeutic Oligos

About the event :

The OTS Annual Meeting brings together leading researchers and industry experts to advance the field of oligonucleotide therapeutics. This premier event fosters collaboration and knowledge sharing, covering a wide range of topics, including antisense, siRNA, immunostimulatory, and aptamer technologies, as well as RNA/DNA editing and mRNA therapeutics.

For more information, visit the event website.

Book a meeting with our team today :

Nom Personne 1

Muriel CRAYNEST

Business Development Manager Proteomics

Nom Personne 2

Rick WILMOTTE

Business Development Manager Proteomics

Don't miss this opportunity to talk with our experts, schedule a meeting today to avoid the line.

Appointment request       

Let's advance science together !

Trending Now

Evolution of Multiplex PCR: Benefits, Challenges & Key Applications

Previous post

Pichia pastoris: benefits and challenges in recombinant protein production

Next post

Recommended for you

Want to keep your in-house IVD assay compli..

Products & Services

Clinical labs often use in-house IVD or Lab Developed Tests (LDTs), when a suitable commercial...
Continue Reading

GMP Plasmid DNA: What it really takes to m..

Products & Services

What exactly does GMP plasmid DNA manufacturing involve? How does it differ from research-grade production?...
Continue Reading
15-17 October 2025

Bioplus Interphex

Seoul, South Korea

Let's meet at "Bioplus Interphex"

@ Seoul, South Korea
📅October 15-17, 2025
📍Seoul, South Korea - Kaneka Corporation's booth H16...
Continue Reading